Rankings
▼
Calendar
ZTS Q2 2025 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena
ZTS
Zoetis Inc.
$54B
Q2 2025 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$2.5B
+4.2% YoY
Gross Profit
$1.8B
72.3% margin
Operating Income
$989M
40.2% margin
Net Income
$718M
29.2% margin
EPS (Diluted)
$1.61
QoQ Revenue Growth
+10.8%
Cash Flow
Operating Cash Flow
$486M
Free Cash Flow
$308M
Stock-Based Comp.
$22M
Balance Sheet
Total Assets
$14.5B
Total Liabilities
$9.5B
Stockholders' Equity
$5.0B
Cash & Equivalents
$1.4B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2.5B
$2.4B
+4.2%
Gross Profit
$1.8B
$1.7B
+7.2%
Operating Income
$989M
$906M
+9.2%
Net Income
$718M
$624M
+15.1%
Revenue Segments
Dogs and Cats
$1.7B
71%
Cattle
$320M
13%
Swine
$119M
5%
Poultry
$103M
4%
Fish
$74M
3%
Horses
$72M
3%
Geographic Segments
United States Segment
$1.4B
56%
International Segment
$1.1B
44%
← FY 2025
All Quarters
Q3 2025 →